KELLY PAUL EDWARD purchased 21.8% of their position (90K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $198.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/6/2025ACC: 0001213900-25-106835
Director
Since Oct 2018
+90K
Net shares
Net buyer
$198.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
90K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+90K
Price / share
$2.20
Trade value
$198K
% of position
21.8%
11/5/2025
412.30K→502.30K
Total
Net shares
+90K
Net value
$198K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2025 | P · Purchase | +90K | $2.20 | $198K | 21.8% | 412.30K | 502.30K |
| Total | +90K | $198K | ||||||
Derivative Transactions0
No derivative transactions reported